{"schema_version":"secwatch.filing_event.v1","accession":"0001504776-24-000003","form_type":"8-K","ticker":"WRBY","cik":"0001504776","company_name":"Warby Parker Inc.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.370913+00:00","generated_at":"2026-06-05T08:40:18.861195+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Warby Parker reports FY 2023 revenue $669.8M (+12% YoY); expands Versant in-network to >34M lives","bullets":["FY 2023 net revenue $669.8M (+12% YoY); Q4 revenue $161.9M (+10.5% YoY).","FY GAAP net loss improved to $63.2M from $110.4M; adjusted EBITDA $52.4M (7.8% margin) vs $27.2M (4.5%).","Expanded Versant Health relationship adds 15M lives, nearly doubling in-network access to >34M; benefits expected later 2024.","FY 2024 guidance: revenue $748-758M (~12-13% growth); adjusted EBITDA ~$67M (8.9% margin); 40 new stores.","Ended 2023 with $216.9M cash; new undrawn $120M revolving credit facility with JPMorgan/Citibank."],"urls":{"canonical":"https://secwatch.observer/filing/0001504776-24-000003","json":"https://secwatch.observer/filing/0001504776-24-000003.json","markdown":"https://secwatch.observer/filing/0001504776-24-000003.md","text":"https://secwatch.observer/filing/0001504776-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1504776/000150477624000003/0001504776-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1504776/000150477624000003/wrby-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T08:40:18.861195+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"307b183748a96f2f3c88849417f3d7f028732a48","claim":"Warby Parker Inc. reported fourth quarter and full year ended December 31, 2023 results: revenue $669.8 million. Guidance reaffirmed.","evidence_excerpt":"forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Warby Parker Announces Fourth Quarter and Full Year 2023 Results 2023 net revenue increased 12.0% to $669.8 million Average revenue per customer increased 9.3% year over year to $287 Expanded relationship with Versant Health, Inc. will nearly double lives with in-network access to >34 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504776/000150477624000003/0001504776-24-000003-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year ended December 31, 2023"},{"label":"Revenue","value":"$669.8 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}